Withdrawal of TNF-alpha after the fifth day of differentiation of CD34+ cord blood progenitors generates a homogeneous population of Langerhans cells and delays their maturation

Exp Dermatol. 2003 Feb;12(1):96-105. doi: 10.1034/j.1600-0625.2003.00043.x.

Abstract

Human cord blood CD34+ progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor-beta (TGF-beta) generate a heterogeneous population of dendritic cells (DC), including Langerhans cells (LC). This combination of cytokines has been shown to be crucial for differentiation into LC. After day 5 of culture, TNF-alpha has been maintained in the medium in most studies despite the observation of spontaneous maturation of LC after day 12. Five-day samples of in vitro differentiated LC were cultured in parallel with or without TNF-alpha. The absence of TNF-alpha was shown to: (1) slow down proliferation without triggering apoptotic cell death, (2) enhance the percentage of LC, (3) delay or abrogate the expression of CD83, CD86, HLA-DR and CD208 molecules, and (4) maintain endocytosis by receptor and macropinocytosis. The withdrawal of TNF-alpha abrogated the spontaneous synthesis of matrix metalloproteinases. At day 12, TNF-alpha-deprived LC were less efficient in allogeneic T cell activation than LC cultivated with TNF-alpha. These data indicate that the suppression of TNF-alpha after day 5 maintains cells in an immature state and provides a population with 80% of LC at day 12.

MeSH terms

  • Antigens, CD34 / blood*
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cell Movement / drug effects
  • Cellular Senescence
  • Drug Administration Schedule
  • Gelatinases / metabolism
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / physiology*
  • Humans
  • Langerhans Cells / cytology
  • Langerhans Cells / enzymology
  • Langerhans Cells / physiology
  • Lymphocyte Culture Test, Mixed
  • Time Factors
  • Tumor Necrosis Factor-alpha / administration & dosage*

Substances

  • Antigens, CD34
  • Tumor Necrosis Factor-alpha
  • Gelatinases